DePuy ASR Hip Lawsuit Update: Plaintiffs Request Deposition Of J&J’s CEO

September 19, 2012

Plaintiffs seek testimony of J&J´s Chief Executive Officer in DePuy ASR hip lawsuits pending in Maryland state court, Bernstein Liebhard LLP reports.

New York, NY (PRWEB) September 19, 2012

Plaintiffs with DePuy ASR hip lawsuits pending in Maryland state court have requested that Alex Gorsky, Chief Executive Officer of Johnson & Johnson testify, Bernstein Liebhard LLP reports.* Plaintiffs in Jackson, et al. v. Chesapeake Orthopaedics, Inc. and DePuy Orthopaedics, Inc., (CAL10-32147), who have lawsuits pending in the Circuit Court of Prince George´s County, Maryland, recently noticed Alex Gorsky to sit for a deposition. According to court documents, plaintiffs argued that “Gorsky oversaw J&J subsidiaries (and co-defendants) DePuy Orthopeadics Inc. and DePuy International Ltd., and was directly involved in decision-making concerning the DePuy ASR device at the center of this suit.” Plaintiffs further argue that “As a result of Mr. Gorsky´s apparent role in the decision-making, testing, study, complaint investigation, continued sale, and subsequent recall of the DePuy ASR device, he has relevant knowledge regarding the subject matter of this litigation, the discovery of which is reasonably calculated to lead to the discovery of admissible evidence.” On September 5, 2012, Johnson & Johnson filed for a protective order and opposed the plaintiffs´ motion to compel Gorsky´s deposition. The Court has not scheduled a hearing or issued a decision as to whether Gorsky will testify. The case is set to go to trial in January 2013.

Since the DePuy ASR hip recall was issued, Bernstein Liebhard LLP has carefully monitored developments and reports on the safety of metal hip implants. In addition, the Firm is representing clients who were implanted with the recalled devices in In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), which is currently underway in the U.S. District Court for the Northern District of Ohio. The first federal DePuy ASR hip recall lawsuit trial is scheduled to begin on May 6, 2013 with the second trial set for July 8, 2013.        

DePuy ASR hip recall lawsuits continue to be filed by Bernstein Liebhard LLP, a nationwide law firm representing clients who have been injured by dangerous drugs and defective medical devices, on behalf of individuals who received DePuy ASR hip implants. Those who have suffered damages as a result of being implanted with a metal-on-metal hip may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries. Learn more by watching this DePuy ASR hip recall video, or by visiting our website, http://www.consumerinjurylawyers.com/DePuy/. For more information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.


About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.


Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP




For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9920319.htm

Source: prweb

comments powered by Disqus